Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 582

1.

Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group.

Marincola Smith P, Baechle J, Solórzano CC, Tan M, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K.

HPB (Oxford). 2019 Dec 2. pii: S1365-182X(19)33183-1. doi: 10.1016/j.hpb.2019.10.2441. [Epub ahead of print]

PMID:
31806388
2.

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.

Khaddour K, Musiek A, Cornelius LA, Dehdashti F, Westervelt P, Fields R, Ansstas G.

J Immunother Cancer. 2019 Dec 4;7(1):338. doi: 10.1186/s40425-019-0801-z.

3.

Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?

Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel SK, Rocha FG.

J Gastrointest Surg. 2019 Nov 20. doi: 10.1007/s11605-019-04431-6. [Epub ahead of print]

PMID:
31749094
4.

Autophagy in Myelinating Glia.

Belgrad J, De Pace R, Fields RD.

J Neurosci. 2019 Nov 19. pii: 1066-19. doi: 10.1523/JNEUROSCI.1066-19.2019. [Epub ahead of print]

PMID:
31744863
5.

Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.

Zhang XF, Wu XN, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(8):1302-1310. doi: 10.1002/jso.25753. Epub 2019 Nov 3.

PMID:
31680243
6.

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA Jr, Kemeny NE, Jarnagin WR.

JAMA Oncol. 2019 Oct 31. doi: 10.1001/jamaoncol.2019.3718. [Epub ahead of print]

PMID:
31670750
7.

Tools for Population Health Management.

Fields RW, Gandhi N.

Prim Care. 2019 Dec;46(4):529-538. doi: 10.1016/j.pop.2019.07.012. Epub 2019 Jul 31. Review.

PMID:
31655749
8.

Differential nucleosome spacing in neurons and glia.

Clark SC, Chereji RV, Lee PR, Fields RD, Clark DJ.

Neurosci Lett. 2020 Jan 1;714:134559. doi: 10.1016/j.neulet.2019.134559. Epub 2019 Oct 19.

PMID:
31639421
9.

Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.

Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1071-1079. doi: 10.1002/jso.25716. Epub 2019 Sep 30.

PMID:
31571225
10.

Coordinated Activity of Transcriptional Networks Responding to the Pattern of Action Potential Firing in Neurons.

Iacobas DA, Iacobas S, Lee PR, Cohen JE, Fields RD.

Genes (Basel). 2019 Sep 26;10(10). pii: E754. doi: 10.3390/genes10100754.

11.

Operationalizing Integrated Immunization and Family Planning Services in Rural Liberia: Lessons Learned From Evaluating Service Quality and Utilization.

Nelson AR, Cooper CM, Kamara S, Taylor ND, Zikeh T, Kanneh-Kesselly C, Fields R, Hossain I, Oseni L, Getahun BS, Fiedler A, Schuster A, Tappis H.

Glob Health Sci Pract. 2019 Sep 26;7(3):418-434. doi: 10.9745/GHSP-D-19-00012. Print 2019 Sep.

12.

Conditional disease-free survival after curative-intent liver resection for neuroendocrine liver metastasis.

Sahara K, Merath K, Tsilimigras DI, Hyer JM, Guglielmi A, Aldrighetti L, Weiss M, Fields RC, Poultsides GA, Maithel SK, Endo I, Pawlik TM, Other Members Of The U S Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1087-1095. doi: 10.1002/jso.25713. Epub 2019 Sep 24.

PMID:
31550406
13.

Correction to: Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.

Spolverato G, Bagante F, Aldrighetti L, Poultsides G, Bauer TW, Fields RC, Marques HP, Weiss M, Maithel SK, Pawlik TM.

J Gastrointest Surg. 2019 Sep 16. doi: 10.1007/s11605-019-04371-1. [Epub ahead of print]

PMID:
31529199
14.

IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.

Li Q, Chen Y, Zhang D, Grossman J, Li L, Khurana N, Jiang H, Grierson PM, Herndon J, DeNardo DG, Challen GA, Liu J, Ruzinova MB, Fields RC, Lim KH.

JCI Insight. 2019 Oct 3;4(19). pii: 130867. doi: 10.1172/jci.insight.130867.

15.

Plasticity of Myelinating Glia.

Fields RD, Richardson WD.

Glia. 2019 Nov;67(11):2005-2007. doi: 10.1002/glia.23720. No abstract available.

PMID:
31515893
16.

Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.

Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.

J Surg Res. 2019 Sep 5;245:577-586. doi: 10.1016/j.jss.2019.08.002. [Epub ahead of print]

PMID:
31494391
17.

Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.

Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI.

J Surg Oncol. 2019 Dec;120(7):1227-1234. doi: 10.1002/jso.25694. Epub 2019 Sep 4.

PMID:
31486096
18.

T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.

Washburn ML, Wang Z, Walton AH, Goedegebuure SP, Figueroa DJ, Van Horn S, Grossman J, Remlinger K, Madsen H, Brown J, Srinivasan R, Wolf AI, Berger SB, Yi VN, Hawkins WG, Fields RC, Hotchkiss RS.

J Immunol. 2019 Oct 1;203(7):1897-1908. doi: 10.4049/jimmunol.1900560. Epub 2019 Sep 4.

PMID:
31484735
19.

Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.

Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM; and other members of the U.S. Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Dec;120(7):1080-1086. doi: 10.1002/jso.25689. Epub 2019 Aug 29.

PMID:
31468550
20.

Motor learning requires myelination to reduce asynchrony and spontaneity in neural activity.

Kato D, Wake H, Lee PR, Tachibana Y, Ono R, Sugio S, Tsuji Y, Tanaka YH, Tanaka YR, Masamizu Y, Hira R, Moorhouse AJ, Tamamaki N, Ikenaka K, Matsukawa N, Fields RD, Nabekura J, Matsuzaki M.

Glia. 2020 Jan;68(1):193-210. doi: 10.1002/glia.23713. Epub 2019 Aug 29.

PMID:
31465122
21.

Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles.

Strand MS, Krasnick BA, Pan H, Zhang X, Bi Y, Brooks C, Wetzel C, Sankpal N, Fleming T, Goedegebuure SP, DeNardo DG, Gillanders WE, Hawkins WG, Wickline SA, Fields RC.

Oncotarget. 2019 Jul 30;10(46):4761-4775. doi: 10.18632/oncotarget.27109. eCollection 2019 Jul 30.

22.

Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?

DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC; other members of the United States Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Nov;120(6):919-925. doi: 10.1002/jso.25662. Epub 2019 Aug 6.

PMID:
31385621
23.

Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?

Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona K.

J Am Coll Surg. 2019 Nov;229(5):449-457. doi: 10.1016/j.jamcollsurg.2019.07.010. Epub 2019 Aug 1.

PMID:
31377411
24.

New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.

Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM.

Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003478. [Epub ahead of print]

PMID:
31356277
25.

A 22-year experience with pancreatic resection for metastatic renal cell carcinoma.

Anderson B, Williams GA, Sanford DE, Lu J, Dageforde LA, Hammill CW, Fields RC, Hawkins WG, Strasberg SM, Doyle MB, Chapman WC, Khan AS.

HPB (Oxford). 2019 Jul 23. pii: S1365-182X(19)30569-6. doi: 10.1016/j.hpb.2019.05.019. [Epub ahead of print]

PMID:
31345661
26.

Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.

Zaidi MY, Ethun CG, Tran TB, Poultsides G, Grignol VP, Howard JH, Bedi M, Mogal H, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields RC, Oskouei S, Reimer N, Monson D, Maithel SK, Cardona K.

Ann Surg Oncol. 2019 Oct;26(11):3542-3549. doi: 10.1245/s10434-019-07639-7. Epub 2019 Jul 24.

PMID:
31342400
27.

Oligodendrocyte involvement in Gulf War Illness.

Belgrad J, Dutta DJ, Bromley-Coolidge S, Kelly KA, Michalovicz LT, Sullivan KA, O'Callaghan JP, Fields RD.

Glia. 2019 Nov;67(11):2107-2124. doi: 10.1002/glia.23668. Epub 2019 Jul 24. Review.

PMID:
31339622
28.

Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).

Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC; and other members of US-NETSG.

J Surg Oncol. 2019 Sep;120(4):632-638. doi: 10.1002/jso.25629. Epub 2019 Jul 24.

PMID:
31339198
29.

Utility of Intraoperative Margin Assessment by Frozen Section in Gastric Cancer.

Squires MH 3rd, Maithel SK, Fields RC.

Ann Surg Oncol. 2019 Oct;26(11):3782-3783. doi: 10.1245/s10434-019-07571-w. Epub 2019 Jul 17. No abstract available.

PMID:
31317379
30.

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.

Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB.

Ann Surg. 2019 Sep;270(3):400-413. doi: 10.1097/SLA.0000000000003468.

PMID:
31283563
31.

A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK.

Ann Surg. 2019 Sep;270(3):422-433. doi: 10.1097/SLA.0000000000003461.

32.

Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC).

Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE.

Sarcoma. 2019 Jun 2;2019:5395131. doi: 10.1155/2019/5395131. eCollection 2019.

33.

Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.

Prendergast KM, Smith PM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC, Kiernan CM.

Surgery. 2019 Jul 1. pii: S0039-6060(19)30286-7. doi: 10.1016/j.surg.2019.05.024. [Epub ahead of print]

PMID:
31272813
34.

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaau9240. doi: 10.1126/scitranslmed.aau9240.

PMID:
31270275
35.

Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.

Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K.

J Surg Oncol. 2019 Sep;120(3):340-347. doi: 10.1002/jso.25606. Epub 2019 Jun 27.

36.

Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence.

Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM.

HPB (Oxford). 2019 Jun 21. pii: S1365-182X(19)30570-2. doi: 10.1016/j.hpb.2019.05.020. [Epub ahead of print]

PMID:
31235429
37.

Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.

Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M.

Gastroenterology. 2019 Sep;157(3):720-730.e2. doi: 10.1053/j.gastro.2019.05.014. Epub 2019 Jun 5.

PMID:
31175863
38.

The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.

Zaidi MY, Ethun CG, Liu Y, Poultsides G, Howard JH, Mogal H, Tseng J, Votanopoulos K, Fields RC, Cardona K.

J Surg Oncol. 2019 Sep;120(3):332-339. doi: 10.1002/jso.25521. Epub 2019 Jun 6.

PMID:
31172536
39.

The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative.

Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M.

J Surg Oncol. 2019 Sep;120(3):325-331. doi: 10.1002/jso.25522. Epub 2019 Jun 6.

PMID:
31172531
40.

Treadmilling Model for Plasticity of the Myelin Sheath.

Fields RD, Dutta DJ.

Trends Neurosci. 2019 Jul;42(7):443-447. doi: 10.1016/j.tins.2019.04.002. Epub 2019 May 8.

PMID:
31078309
41.

In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3?

Mogal H, Fields R, Maithel SK, Votanopoulos K.

Ann Surg Oncol. 2019 Sep;26(9):2912-2932. doi: 10.1245/s10434-019-07417-5. Epub 2019 May 10.

PMID:
31076930
42.

Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.

Jiang H, Liu X, Knolhoff BL, Hegde S, Lee KB, Jiang H, Fields RC, Pachter JA, Lim KH, DeNardo DG.

Gut. 2020 Jan;69(1):122-132. doi: 10.1136/gutjnl-2018-317424. Epub 2019 May 10.

PMID:
31076405
43.

The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.

Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, Fields RC, Idrees K, Cho CS, Abbott DE, Cardona K, Maithel SK.

Surgery. 2019 Jul;166(1):15-21. doi: 10.1016/j.surg.2019.03.008. Epub 2019 May 6.

PMID:
31072670
44.

Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.

Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK.

Ann Surg Oncol. 2019 Aug;26(8):2517-2524. doi: 10.1245/s10434-019-07367-y. Epub 2019 Apr 19.

PMID:
31004295
45.

Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.

Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Aug;120(2):231-240. doi: 10.1002/jso.25481. Epub 2019 Apr 18.

PMID:
31001868
46.

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, Engh AM.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):367-402. doi: 10.6004/jnccn.2019.0018.

PMID:
30959471
47.

Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group.

Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME.

J Gastrointest Surg. 2019 Nov;23(11):2225-2231. doi: 10.1007/s11605-019-04120-4. Epub 2019 Apr 2.

PMID:
30941685
48.

Rheumatology Care in Under-Resourced Areas Utilizing the ECHO Model.

Bankhurst A, Olivas C, Larson JH, Bradford A, Fields R, Kalishman S, Marquez M, Gonzales Van Horn S, Swift R, Rochelle R, Jones J, Burke T, Snead J, Arora S.

Arthritis Care Res (Hoboken). 2019 Mar 30. doi: 10.1002/acr.23889. [Epub ahead of print]

PMID:
30927517
49.

Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.

Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK.

Ann Surg Oncol. 2019 Jun;26(6):1814-1823. doi: 10.1245/s10434-019-07306-x. Epub 2019 Mar 15.

PMID:
30877497
50.

Is Dedicated Research Time During Surgery Residency Associated With Surgeons' Future Career Paths?: A National Study.

Andriole DA, Klingensmith ME, Fields RC, Jeffe DB.

Ann Surg. 2018 Aug 24. doi: 10.1097/SLA.0000000000003015. [Epub ahead of print]

PMID:
30829693

Supplemental Content

Loading ...
Support Center